ROBLE, BELKO & COMPANY, INC – AstraZeneca PLC Transaction History
ROBLE, BELKO & COMPANY, INC portfolio value:
$29,000
portfolio value
ROBLE, BELKO & COMPANY, INC quarter portfolio value change:
-17.00%
quarter
AstraZeneca PLC 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -5K | $54.84 | 520 | |
| Q2 2022 | share | 0.00% | 0 shares | 0 | $66.07 | 520 | |
| Q1 2022 | share | 0.00% | 0 shares | 4K | $66.34 | 520 | |
| Q4 2021 | share | 0.00% | 0 shares | -1K | $58.47 | 520 | |
| Q3 2021 | share | 0.00% | 0 shares | 0 | $60.06 | 520 | |
| Q2 2021 | share | 0.00% | 0 shares | 5K | $59.44 | 520 | |
| Q1 2021 | share | 0.00% | 0 shares | 0 | $49.34 | 520 | |
| Q4 2020 | share | 0.00% | 0 shares | -2K | $48.68 | 520 | |
| Q3 2020 | share | 0.00% | 0 shares | 0 | $53.37 | 520 | |
| Q2 2020 | share | 0.00% | 0 shares | 5K | $51.1 | 520 | |
| Q1 2020 | share | 0.00% | 0 shares | -3K | $43.15 | 520 | |
| Q4 2019 | share | 0.00% | 0 shares | 3K | $47.17 | 520 | |
| Q3 2019 | share | 0.00% | 0 shares | 2K | $42.17 | 520 | |
| Q2 2019 | share | 0.00% | 0 shares | 0 | $38.66 | 520 | |
| Q1 2019 | share | 0.00% | 0 shares | 1K | $37.87 | 520 | |
| Q4 2018 | share | 0.00% | 0 shares | -1K | $34.78 | 520 | |
| Q3 2018 | share | 0.00% | 0 shares | 3K | $36.23 | 520 | |
| Q2 2018 | share | 0.00% | 0 shares | 0 | $31.79 | 520 | |
| Q1 2018 | share | 0.00% | 0 shares | 0 | $31.66 | 520 | |
| Q4 2017 | share | 0.00% | 0 shares | 0 | $30.56 | 520 | |
| Q3 2017 | share | 0.00% | 0 shares | 0 | $29.84 | 520 | |
| Q2 2017 | share | 0.00% | 0 shares | 2K | $29.58 | 520 | |
| Q1 2017 | share | 0.00% | 0 shares | 2K | $27.02 | 520 | |
| Q4 2016 | share | 0.00% | 0 shares | -3K | $22.97 | 520 | |
| Q3 2016 | share | 0.00% | 0 shares | 1K | $27.63 | 520 | |
| Q2 2016 | share | 0.00% | 0 shares | 1K | $25.05 | 520 | |
| Q1 2016 | share | 0.00% | 0 shares | -3K | $23.37 | 520 |